Immunotherapy

CAR‑T Cells Targeting GPNMB Eradicate Glioblastoma in Preclinical Models

A single engineered T cell that recognises GPNMB can attack tumour cells by also targeting the macrophages that support them, requiring further safety studies before human trials.